Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.

Source:http://linkedlifedata.com/resource/pubmed/id/8890721

Download in:

View as

General Info

PMID
8890721